Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Cardiovascular Diabetology Année : 2016

Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study

Résumé

To investigate whether atherogenic dyslipidemia, a dyslipidemic profile combining elevated triglycerides and low high-density lipoprotein (HDL) cholesterol, is predictive of risk of silent myocardial ischemia (SMI) or angiographic coronary artery disease (CAD) in asymptomatic patients with type 2 diabetes.
Fichier principal
Vignette du fichier
2016 Valensi et al., Atherogenic dyslipidemia.pdf (27.54 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01818507 , version 1 (29-03-2020)

Licence

Identifiants

Citer

Paul Valensi, Antoine Avignon, Ariane Sultan, Bernard Chanu, Minh Tuan Nguyen, et al.. Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Cardiovascular Diabetology, 2016, 15 (1), pp.104. ⟨10.1186/s12933-016-0415-4⟩. ⟨hal-01818507⟩
77 Consultations
39 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More